Clinical consequences of 2′-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 10 (8), 989-993
- https://doi.org/10.1016/0145-2126(86)90251-1
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemiaBritish Journal of Haematology, 1984
- The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancyBlood, 1984
- A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five casesBlood, 1983
- THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIAThe Lancet, 1981
- The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyBlood, 1981
- Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivoBlood, 1980
- REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1980
- Isolation of 2'-deoxycoformycin and cordycepin from wheat bran culture of Aspergillus nidulans Y 176-2.Agricultural and Biological Chemistry, 1979
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977
- A novel adenosine and ara‐a deaminase inhibitor, (R)‐3‐(2‐deoxy‐β‐D‐erythro‐pentofuranosyl)‐3,6,7,8‐tetrahydroimidazo[4,5 ‐d] [1,3]diazepin‐8‐olJournal of Heterocyclic Chemistry, 1974